Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 2746 AL 2760

Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases

Chen X, Barclay JW, Burgoyne RD, Morgan A.

Chem Cent J. 2015 Nov 26;9:65. doi: 10.1186/s13065-015-0143-y. eCollection 2015.

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease

van Wamelen DJ, Roos RA, Aziz NA.

Neurodegener Dis Manag. 2015 Dec;5(6):549-59. doi: 10.2217/nmt.15.45. Epub 2015 Dec 1.

Intravenous immunoglobulin in acute Sydenham's chorea: A systematic review

Mohammad SS, Nosadini M, Grattan-Smith P, Dale RC.

J Paediatr Child Health. 2015 Dec;51(12):1235-8. doi: 10.1111/jpc.12915.

Moving toward a gene therapy for Huntington's disease

Glorioso JC, Cohen JB, Carlisle DL, Munoz-Sanjuan I, Friedlander RM.

Gene Ther. 2015 Dec;22(12):931-3. doi: 10.1038/gt.2015.102.

microRNAs and Neurodegenerative Diseases

Qiu L, Tan EK, Zeng L.

Adv Exp Med Biol. 2015;888:85-105. doi: 10.1007/978-3-319-22671-2_6.

Dystonia and Paroxysmal Dyskinesias: Under-Recognized Movement Disorders in Domestic Animals? A Comparison with Human Dystonia/Paroxysmal Dyskinesias

Richter A, Hamann M, Wissel J, Volk HA.

Front Vet Sci. 2015 Nov 30;2:65. doi: 10.3389/fvets.2015.00065. eCollection 2015.

Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges

Kerkis I, Haddad MS, Valverde CW, Glosman S.

Stem Cell Res Ther. 2015 Dec 14;6:232. doi: 10.1186/s13287-015-0248-1.

PET Imaging in Huntington's Disease

Roussakis AA, Piccini P.

J Huntingtons Dis. 2015;4(4):287-96. doi: 10.3233/JHD-150171.

The Impact of Huntington Disease on Family Carers: a Literature Overview

Domaradzki J.

Psychiatr Pol. 2015;49(5):931-44. doi: 10.12740/PP/34496.

Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington's disease are not reflected in mutant Huntingtin inclusion prevalence

Bayram-Weston Z, Stone TC, Giles P, Elliston L, Janghra N, Higgs GV, Holmans PA, Dunnett SB, Brooks SP, Jones L.

BMC Genomics. 2015 Dec 21;16:1079. doi: 10.1186/s12864-015-2251-4.

How to Capitalize on the Retest Effect in Future Trials on Huntington's Disease

Schramm C, Katsahian S, Youssov K, Démonet JF, Krystkowiak P, Supiot F, Verny C, Cleret de Langavant L, Bachoud-Lévi AC; European Huntington's Disease Initiative Study Group and the Multicentre Intracerebral Grafting in Huntington's Disease Group.

PLoS One. 2015 Dec 29;10(12):e0145842. doi: 10.1371/journal.pone.0145842. eCollection 2015.

Induced pluripotent stem cells for modeling neurological disorders

Russo FB, Cugola FR, Fernandes IR, Pignatari GC, Beltrão-Braga PC.

World J Transplant. 2015 Dec 24;5(4):209-21. doi: 10.5500/wjt.v5.i4.209.

Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?

Lewerenz J, Maher P.

Front Neurosci. 2015 Dec 16;9:469. doi: 10.3389/fnins.2015.00469. eCollection 2015.

Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease

Gregory S, Cole JH, Farmer RE, Rees EM, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Zhang H, Scahill RI, Tabrizi SJ, Frost C, Hobbs NZ.

J Huntingtons Dis. 2015;4(4):333-46. doi: 10.3233/JHD-150173.

The Neuropathology of Huntington´s disease: classical findings, recent developments and correlation to functional neuroanatomy

Rüb U, Vonsattel JP, Heinsen H, Korf HW.

Adv Anat Embryol Cell Biol. 2015;217:1-146.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias